Trial Profile
Prevention of Atrial Fibrillation by the Prescription of Inhibition Conversion Enzyme (ICE) After Radiofrequency Ablation of Atrial Flutter
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramipril (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms PREFACE
- 30 Oct 2021 Results investigating the effect of ramipril compared with placebo on AF occurrence in patients hospitalized for AFL ablation without structural heart disease published in the American Journal of Cardiology
- 27 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 23 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.